Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Cardiovascular events during differing hypertension therapies in patients with diabetes.

Weber MA, Bakris GL, Jamerson K, Weir M, Kjeldsen SE, Devereux RB, Velazquez EJ, Dahlöf B, Kelly RY, Hua TA, Hester A, Pitt B; ACCOMPLISH Investigators.

J Am Coll Cardiol. 2010 Jun 29;56(1):77-85. doi: 10.1016/j.jacc.2010.02.046.

2.

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA; ACCOMPLISH Trial investigators.

Lancet. 2010 Apr 3;375(9721):1173-81. doi: 10.1016/S0140-6736(09)62100-0. Epub 2010 Feb 18.

PMID:
20170948
3.

24-hour ambulatory blood pressure in the ACCOMPLISH trial.

Jamerson KA, Bakris GL, Weber MA.

N Engl J Med. 2010 Jul 1;363(1):98. doi: 10.1056/NEJMc1001410. No abstract available.

4.
5.

Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.

Roca-Cusachs A, Schmieder RE, Triposkiadis F, Wenzel RR, Laurent S, Kohlmann O Jr, Fogari R; MORE Study Group.

J Hypertens. 2008 Apr;26(4):813-8. doi: 10.1097/HJH.0b013e3282f3b5f0.

PMID:
18327093
7.

The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.

Bakris G, Hester A, Weber M, Dahlof B, Pitt B, Velasquez E, Staikos-Byrne L, Shi V, Jamerson K; ACCOMPLISH Investigators.

J Cardiometab Syndr. 2008 Fall;3(4):229-33. doi: 10.1111/j.1559-4572.2008.00023.x.

8.

The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH).

Jamerson KA; Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension Trial.

J Clin Hypertens (Greenwich). 2003 Jul-Aug;5(4 Suppl 3):29-35.

9.

Benazepril plus amlodipine or hydrochlorothiazide for hypertension.

Davis BR, Whelton PK; ALLHAT Collaborative Research Group.

N Engl J Med. 2009 Mar 12;360(11):1148-9; author reply 1149-50. No abstract available.

PMID:
19283889
11.

Hypertension: an ACCOMPLISHED regimen for hypertension.

Turnbull F.

Nat Rev Nephrol. 2009 Apr;5(4):183-4. doi: 10.1038/nrneph.2009.25. No abstract available.

PMID:
19322179
12.

Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.

Mourad JJ, Le Jeune S, Pirollo A, Mourad C, Gaudouen Y, Lopez-Sublet M.

Curr Med Res Opin. 2010 Sep;26(9):2263-76. doi: 10.1185/03007995.2010.510925. Review.

PMID:
20690889
13.

Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension.

Izzo JL Jr, Purkayastha D, Hall D, Hilkert RJ.

J Hum Hypertens. 2010 Jun;24(6):403-9. doi: 10.1038/jhh.2009.80. Epub 2009 Nov 5.

PMID:
19890370
14.

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.

Clin Ther. 2007 Feb;29(2):279-89.

PMID:
17472820
15.

Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension.

Ferdinand KC, Weitzman R, Israel M, Lee J, Purkayastha D, Jaimes EA.

J Am Soc Hypertens. 2011 Mar-Apr;5(2):102-13. doi: 10.1016/j.jash.2011.01.006.

PMID:
21414565
17.

Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials.

Lv Y, Zou Z, Chen GM, Jia HX, Zhong J, Fang WW.

Blood Press Monit. 2010 Aug;15(4):195-204. doi: 10.1097/MBP.0b013e32833a23d4.

PMID:
20512032
18.
19.

Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo.

Kuschnir E, Acuña E, Sevilla D, Vasquez J, Bendersky M, Resk J, Glazer R.

Clin Ther. 1996 Nov-Dec;18(6):1213-24.

PMID:
9001838
20.

Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Piller LB, Ford CE, Davis BR, Nwachuku C, Black HR, Oparil S, Retta TM, Probstfield JL; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2006 Sep;8(9):649-56; quiz 657-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk